When COVID-19 emerged, Adarza BioSystems (like many companies) pivoted. Before the pandemic, Adarza had developed a label-free immune profiling system for cytokines and chemokines, and the company had planned for the system to serve immuno-oncology and neurology research. But after the pandemic started, Adarza adapted the system to profile SARS-CoV-2 and other viruses. The profiling […]

Dr. Scott Sigman, Founder and CMO of OrthoLazer and Team Physician at UMASS Lowell, discusses the publication of a second case report demonstrating positive outcomes for a COVID-19 patient treated with adjunct laser therapy. The patient is part of a randomized clinical pilot trial. The treatment is once-daily for four days using an FDA-cleared laser. […]

Dr. Scott Sigman, Founder and CMO of OrthoLazer and Team Physician at UMASS Lowell, discusses the publication of a second case report demonstrating positive outcomes for a COVID-19 patient treated with adjunct laser therapy. The patient is part of a randomized clinical pilot trial. The treatment is once-daily for four days using an FDA-cleared laser. […]